nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—UGT2B7—Epirubicin—uterine cancer	0.159	0.191	CbGbCtD
Flunitrazepam—CYP2A6—Progesterone—uterine cancer	0.142	0.171	CbGbCtD
Flunitrazepam—UGT1A1—Etoposide—uterine cancer	0.107	0.129	CbGbCtD
Flunitrazepam—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0739	0.0888	CbGbCtD
Flunitrazepam—CYP2C19—Progesterone—uterine cancer	0.0588	0.0707	CbGbCtD
Flunitrazepam—CYP1A2—Progesterone—uterine cancer	0.0543	0.0653	CbGbCtD
Flunitrazepam—CYP2C9—Progesterone—uterine cancer	0.0489	0.0588	CbGbCtD
Flunitrazepam—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0429	0.0516	CbGbCtD
Flunitrazepam—CYP2E1—Etoposide—uterine cancer	0.042	0.0505	CbGbCtD
Flunitrazepam—CYP3A4—Progesterone—uterine cancer	0.0284	0.0342	CbGbCtD
Flunitrazepam—CYP2B6—Doxorubicin—uterine cancer	0.0283	0.034	CbGbCtD
Flunitrazepam—CYP1A2—Etoposide—uterine cancer	0.0243	0.0292	CbGbCtD
Flunitrazepam—CYP3A4—Etoposide—uterine cancer	0.0127	0.0153	CbGbCtD
Flunitrazepam—CYP3A4—Doxorubicin—uterine cancer	0.00868	0.0104	CbGbCtD
Flunitrazepam—Slurred speech—Progesterone—uterine cancer	0.00653	0.0589	CcSEcCtD
Flunitrazepam—Balance disorder—Medroxyprogesterone Acetate—uterine cancer	0.00484	0.0436	CcSEcCtD
Flunitrazepam—TSPO—oviduct—uterine cancer	0.00433	0.123	CbGeAlD
Flunitrazepam—Aggression—Progesterone—uterine cancer	0.00333	0.03	CcSEcCtD
Flunitrazepam—Dysarthria—Progesterone—uterine cancer	0.00309	0.0278	CcSEcCtD
Flunitrazepam—TSPO—artery—uterine cancer	0.00287	0.0816	CbGeAlD
Flunitrazepam—Dysarthria—Medroxyprogesterone Acetate—uterine cancer	0.0028	0.0252	CcSEcCtD
Flunitrazepam—TSPO—exocrine gland—uterine cancer	0.0025	0.0711	CbGeAlD
Flunitrazepam—Sleep disorder—Progesterone—uterine cancer	0.00245	0.0221	CcSEcCtD
Flunitrazepam—Disorientation—Progesterone—uterine cancer	0.00237	0.0214	CcSEcCtD
Flunitrazepam—Diplopia—Progesterone—uterine cancer	0.00212	0.0191	CcSEcCtD
Flunitrazepam—Amnesia—Medroxyprogesterone Acetate—uterine cancer	0.00205	0.0184	CcSEcCtD
Flunitrazepam—Irritability—Progesterone—uterine cancer	0.00202	0.0182	CcSEcCtD
Flunitrazepam—Psychotic disorder—Medroxyprogesterone Acetate—uterine cancer	0.00188	0.0169	CcSEcCtD
Flunitrazepam—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.0165	CcSEcCtD
Flunitrazepam—Ataxia—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.0163	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.0158	CcSEcCtD
Flunitrazepam—UGT2B7—renal system—uterine cancer	0.00172	0.0489	CbGeAlD
Flunitrazepam—Muscular weakness—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.0153	CcSEcCtD
Flunitrazepam—Drowsiness—Progesterone—uterine cancer	0.00163	0.0147	CcSEcCtD
Flunitrazepam—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.0133	CcSEcCtD
Flunitrazepam—UGT1A1—renal system—uterine cancer	0.00146	0.0416	CbGeAlD
Flunitrazepam—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.0128	CcSEcCtD
Flunitrazepam—TSPO—myometrium—uterine cancer	0.00139	0.0394	CbGeAlD
Flunitrazepam—UGT2B7—female reproductive system—uterine cancer	0.00138	0.0392	CbGeAlD
Flunitrazepam—GABRA4—mammalian vulva—uterine cancer	0.00133	0.0379	CbGeAlD
Flunitrazepam—Tremor—Progesterone—uterine cancer	0.0012	0.0108	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Progesterone—uterine cancer	0.00119	0.0107	CcSEcCtD
Flunitrazepam—Angioedema—Progesterone—uterine cancer	0.00117	0.0105	CcSEcCtD
Flunitrazepam—Malaise—Progesterone—uterine cancer	0.00115	0.0104	CcSEcCtD
Flunitrazepam—TSPO—epithelium—uterine cancer	0.00109	0.0309	CbGeAlD
Flunitrazepam—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00977	CcSEcCtD
Flunitrazepam—Anxiety—Progesterone—uterine cancer	0.00108	0.00977	CcSEcCtD
Flunitrazepam—TSPO—uterine cervix—uterine cancer	0.00108	0.0307	CbGeAlD
Flunitrazepam—Discomfort—Progesterone—uterine cancer	0.00107	0.00968	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00968	CcSEcCtD
Flunitrazepam—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00959	CcSEcCtD
Flunitrazepam—Dry mouth—Progesterone—uterine cancer	0.00106	0.00959	CcSEcCtD
Flunitrazepam—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00953	CcSEcCtD
Flunitrazepam—Confusional state—Progesterone—uterine cancer	0.00105	0.00947	CcSEcCtD
Flunitrazepam—TSPO—smooth muscle tissue—uterine cancer	0.00105	0.0298	CbGeAlD
Flunitrazepam—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00941	CcSEcCtD
Flunitrazepam—TSPO—decidua—uterine cancer	0.00103	0.0292	CbGeAlD
Flunitrazepam—Tachycardia—Progesterone—uterine cancer	0.00102	0.00917	CcSEcCtD
Flunitrazepam—TSPO—renal system—uterine cancer	0.00101	0.0287	CbGeAlD
Flunitrazepam—Hyperhidrosis—Progesterone—uterine cancer	0.00101	0.00908	CcSEcCtD
Flunitrazepam—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000982	0.00885	CcSEcCtD
Flunitrazepam—TSPO—endometrium—uterine cancer	0.000976	0.0277	CbGeAlD
Flunitrazepam—Hypotension—Progesterone—uterine cancer	0.000974	0.00878	CcSEcCtD
Flunitrazepam—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000974	0.00878	CcSEcCtD
Flunitrazepam—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000964	0.00869	CcSEcCtD
Flunitrazepam—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000952	0.00858	CcSEcCtD
Flunitrazepam—TSPO—mammalian vulva—uterine cancer	0.000944	0.0268	CbGeAlD
Flunitrazepam—Somnolence—Progesterone—uterine cancer	0.000927	0.00835	CcSEcCtD
Flunitrazepam—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000922	0.00831	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000913	0.00823	CcSEcCtD
Flunitrazepam—TSPO—uterus—uterine cancer	0.0009	0.0256	CbGeAlD
Flunitrazepam—Fatigue—Progesterone—uterine cancer	0.000899	0.0081	CcSEcCtD
Flunitrazepam—CYP2A6—vagina—uterine cancer	0.000894	0.0254	CbGeAlD
Flunitrazepam—Dysarthria—Epirubicin—uterine cancer	0.000886	0.00798	CcSEcCtD
Flunitrazepam—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000883	0.00796	CcSEcCtD
Flunitrazepam—Feeling abnormal—Progesterone—uterine cancer	0.000859	0.00774	CcSEcCtD
Flunitrazepam—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00084	0.00757	CcSEcCtD
Flunitrazepam—Hiccups—Epirubicin—uterine cancer	0.000838	0.00755	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Dactinomycin—uterine cancer	0.000838	0.00755	CcSEcCtD
Flunitrazepam—Dysarthria—Doxorubicin—uterine cancer	0.00082	0.00739	CcSEcCtD
Flunitrazepam—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000814	0.00734	CcSEcCtD
Flunitrazepam—Malaise—Dactinomycin—uterine cancer	0.000814	0.00734	CcSEcCtD
Flunitrazepam—TSPO—female reproductive system—uterine cancer	0.000809	0.023	CbGeAlD
Flunitrazepam—GABRA2—vagina—uterine cancer	0.00079	0.0225	CbGeAlD
Flunitrazepam—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000778	0.00702	CcSEcCtD
Flunitrazepam—Hiccups—Doxorubicin—uterine cancer	0.000775	0.00699	CcSEcCtD
Flunitrazepam—Discomfort—Dactinomycin—uterine cancer	0.000759	0.00684	CcSEcCtD
Flunitrazepam—Asthenia—Progesterone—uterine cancer	0.000748	0.00674	CcSEcCtD
Flunitrazepam—TSPO—female gonad—uterine cancer	0.000736	0.0209	CbGeAlD
Flunitrazepam—TSPO—vagina—uterine cancer	0.000731	0.0208	CbGeAlD
Flunitrazepam—Dizziness—Progesterone—uterine cancer	0.000689	0.00621	CcSEcCtD
Flunitrazepam—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000678	0.00611	CcSEcCtD
Flunitrazepam—Rash—Progesterone—uterine cancer	0.000657	0.00592	CcSEcCtD
Flunitrazepam—Dermatitis—Progesterone—uterine cancer	0.000657	0.00592	CcSEcCtD
Flunitrazepam—Headache—Progesterone—uterine cancer	0.000653	0.00589	CcSEcCtD
Flunitrazepam—CYP1A2—renal system—uterine cancer	0.000648	0.0184	CbGeAlD
Flunitrazepam—Fatigue—Dactinomycin—uterine cancer	0.000635	0.00573	CcSEcCtD
Flunitrazepam—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000625	0.00563	CcSEcCtD
Flunitrazepam—CYP2B6—renal system—uterine cancer	0.000622	0.0177	CbGeAlD
Flunitrazepam—Diplopia—Epirubicin—uterine cancer	0.000608	0.00548	CcSEcCtD
Flunitrazepam—Feeling abnormal—Dactinomycin—uterine cancer	0.000607	0.00547	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Etoposide—uterine cancer	0.000606	0.00546	CcSEcCtD
Flunitrazepam—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000596	0.00537	CcSEcCtD
Flunitrazepam—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000595	0.00536	CcSEcCtD
Flunitrazepam—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000592	0.00533	CcSEcCtD
Flunitrazepam—Malaise—Etoposide—uterine cancer	0.000589	0.00531	CcSEcCtD
Flunitrazepam—CYP2E1—renal system—uterine cancer	0.000583	0.0166	CbGeAlD
Flunitrazepam—CYP2C19—vagina—uterine cancer	0.000575	0.0163	CbGeAlD
Flunitrazepam—Ataxia—Epirubicin—uterine cancer	0.000572	0.00515	CcSEcCtD
Flunitrazepam—Diplopia—Doxorubicin—uterine cancer	0.000563	0.00507	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Epirubicin—uterine cancer	0.000555	0.00501	CcSEcCtD
Flunitrazepam—Discomfort—Etoposide—uterine cancer	0.00055	0.00495	CcSEcCtD
Flunitrazepam—Confusional state—Etoposide—uterine cancer	0.000538	0.00485	CcSEcCtD
Flunitrazepam—Muscular weakness—Epirubicin—uterine cancer	0.000536	0.00483	CcSEcCtD
Flunitrazepam—Ataxia—Doxorubicin—uterine cancer	0.000529	0.00477	CcSEcCtD
Flunitrazepam—Asthenia—Dactinomycin—uterine cancer	0.000529	0.00476	CcSEcCtD
Flunitrazepam—Tachycardia—Etoposide—uterine cancer	0.00052	0.00469	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Etoposide—uterine cancer	0.000516	0.00465	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000514	0.00463	CcSEcCtD
Flunitrazepam—GABRA2—lymph node—uterine cancer	0.000511	0.0145	CbGeAlD
Flunitrazepam—Hypotension—Etoposide—uterine cancer	0.000498	0.00449	CcSEcCtD
Flunitrazepam—CYP2B6—female reproductive system—uterine cancer	0.000498	0.0141	CbGeAlD
Flunitrazepam—Muscular weakness—Doxorubicin—uterine cancer	0.000496	0.00447	CcSEcCtD
Flunitrazepam—CYP2C9—female reproductive system—uterine cancer	0.000493	0.014	CbGeAlD
Flunitrazepam—Somnolence—Etoposide—uterine cancer	0.000474	0.00427	CcSEcCtD
Flunitrazepam—TSPO—lymph node—uterine cancer	0.000473	0.0134	CbGeAlD
Flunitrazepam—CYP3A4—renal system—uterine cancer	0.000469	0.0133	CbGeAlD
Flunitrazepam—Drowsiness—Epirubicin—uterine cancer	0.000469	0.00422	CcSEcCtD
Flunitrazepam—CYP2E1—female reproductive system—uterine cancer	0.000467	0.0133	CbGeAlD
Flunitrazepam—Rash—Dactinomycin—uterine cancer	0.000465	0.00419	CcSEcCtD
Flunitrazepam—Fatigue—Etoposide—uterine cancer	0.00046	0.00414	CcSEcCtD
Flunitrazepam—CYP2B6—vagina—uterine cancer	0.00045	0.0128	CbGeAlD
Flunitrazepam—Sweating—Epirubicin—uterine cancer	0.000449	0.00405	CcSEcCtD
Flunitrazepam—Feeling abnormal—Etoposide—uterine cancer	0.000439	0.00396	CcSEcCtD
Flunitrazepam—Drowsiness—Doxorubicin—uterine cancer	0.000434	0.00391	CcSEcCtD
Flunitrazepam—Sweating—Doxorubicin—uterine cancer	0.000416	0.00375	CcSEcCtD
Flunitrazepam—Asthenia—Etoposide—uterine cancer	0.000383	0.00345	CcSEcCtD
Flunitrazepam—CYP3A4—female reproductive system—uterine cancer	0.000376	0.0107	CbGeAlD
Flunitrazepam—Dizziness—Etoposide—uterine cancer	0.000353	0.00318	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Epirubicin—uterine cancer	0.00034	0.00306	CcSEcCtD
Flunitrazepam—Agitation—Epirubicin—uterine cancer	0.000337	0.00303	CcSEcCtD
Flunitrazepam—Rash—Etoposide—uterine cancer	0.000336	0.00303	CcSEcCtD
Flunitrazepam—Dermatitis—Etoposide—uterine cancer	0.000336	0.00303	CcSEcCtD
Flunitrazepam—Headache—Etoposide—uterine cancer	0.000334	0.00301	CcSEcCtD
Flunitrazepam—Malaise—Epirubicin—uterine cancer	0.00033	0.00298	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Doxorubicin—uterine cancer	0.000314	0.00283	CcSEcCtD
Flunitrazepam—Agitation—Doxorubicin—uterine cancer	0.000311	0.00281	CcSEcCtD
Flunitrazepam—Anxiety—Epirubicin—uterine cancer	0.000311	0.0028	CcSEcCtD
Flunitrazepam—Discomfort—Epirubicin—uterine cancer	0.000308	0.00278	CcSEcCtD
Flunitrazepam—Malaise—Doxorubicin—uterine cancer	0.000306	0.00275	CcSEcCtD
Flunitrazepam—Dry mouth—Epirubicin—uterine cancer	0.000305	0.00275	CcSEcCtD
Flunitrazepam—Confusional state—Epirubicin—uterine cancer	0.000301	0.00272	CcSEcCtD
Flunitrazepam—Tachycardia—Epirubicin—uterine cancer	0.000292	0.00263	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Epirubicin—uterine cancer	0.000289	0.0026	CcSEcCtD
Flunitrazepam—Anxiety—Doxorubicin—uterine cancer	0.000288	0.00259	CcSEcCtD
Flunitrazepam—Discomfort—Doxorubicin—uterine cancer	0.000285	0.00257	CcSEcCtD
Flunitrazepam—Dry mouth—Doxorubicin—uterine cancer	0.000282	0.00254	CcSEcCtD
Flunitrazepam—Hypotension—Epirubicin—uterine cancer	0.000279	0.00252	CcSEcCtD
Flunitrazepam—Confusional state—Doxorubicin—uterine cancer	0.000279	0.00251	CcSEcCtD
Flunitrazepam—Tachycardia—Doxorubicin—uterine cancer	0.00027	0.00243	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Doxorubicin—uterine cancer	0.000267	0.00241	CcSEcCtD
Flunitrazepam—Somnolence—Epirubicin—uterine cancer	0.000266	0.0024	CcSEcCtD
Flunitrazepam—Hypotension—Doxorubicin—uterine cancer	0.000258	0.00233	CcSEcCtD
Flunitrazepam—Fatigue—Epirubicin—uterine cancer	0.000258	0.00232	CcSEcCtD
Flunitrazepam—Feeling abnormal—Epirubicin—uterine cancer	0.000246	0.00222	CcSEcCtD
Flunitrazepam—Somnolence—Doxorubicin—uterine cancer	0.000246	0.00222	CcSEcCtD
Flunitrazepam—Fatigue—Doxorubicin—uterine cancer	0.000238	0.00215	CcSEcCtD
Flunitrazepam—Feeling abnormal—Doxorubicin—uterine cancer	0.000228	0.00205	CcSEcCtD
Flunitrazepam—Asthenia—Epirubicin—uterine cancer	0.000214	0.00193	CcSEcCtD
Flunitrazepam—Asthenia—Doxorubicin—uterine cancer	0.000198	0.00179	CcSEcCtD
Flunitrazepam—Dizziness—Epirubicin—uterine cancer	0.000198	0.00178	CcSEcCtD
Flunitrazepam—Rash—Epirubicin—uterine cancer	0.000188	0.0017	CcSEcCtD
Flunitrazepam—Dermatitis—Epirubicin—uterine cancer	0.000188	0.0017	CcSEcCtD
Flunitrazepam—Headache—Epirubicin—uterine cancer	0.000187	0.00169	CcSEcCtD
Flunitrazepam—Dizziness—Doxorubicin—uterine cancer	0.000183	0.00165	CcSEcCtD
Flunitrazepam—Rash—Doxorubicin—uterine cancer	0.000174	0.00157	CcSEcCtD
Flunitrazepam—Dermatitis—Doxorubicin—uterine cancer	0.000174	0.00157	CcSEcCtD
Flunitrazepam—Headache—Doxorubicin—uterine cancer	0.000173	0.00156	CcSEcCtD
Flunitrazepam—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	4.64e-05	0.00211	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	4.63e-05	0.0021	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	4.58e-05	0.00208	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	4.49e-05	0.00204	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	4.43e-05	0.00201	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.37e-05	0.00198	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—AKR1B1—uterine cancer	4.33e-05	0.00197	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—STAR—uterine cancer	4.33e-05	0.00197	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	4.18e-05	0.0019	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—NDUFB11—uterine cancer	4.14e-05	0.00188	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—SRD5A2—uterine cancer	4.14e-05	0.00188	CbGpPWpGaD
Flunitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	4.1e-05	0.00186	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	4.07e-05	0.00185	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.98e-05	0.00181	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	3.83e-05	0.00174	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	3.78e-05	0.00172	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—AKR1B1—uterine cancer	3.68e-05	0.00167	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—STAR—uterine cancer	3.68e-05	0.00167	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	3.68e-05	0.00167	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	3.68e-05	0.00167	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	3.62e-05	0.00164	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	3.58e-05	0.00163	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	3.57e-05	0.00162	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	3.57e-05	0.00162	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	3.54e-05	0.00161	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.4e-05	0.00155	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—POLD1—uterine cancer	3.4e-05	0.00154	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	3.3e-05	0.0015	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	3.27e-05	0.00148	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	3.26e-05	0.00148	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	3.23e-05	0.00147	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	3.23e-05	0.00147	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—SRD5A2—uterine cancer	3.19e-05	0.00145	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—NDUFB11—uterine cancer	3.19e-05	0.00145	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—AKR1C1—uterine cancer	3.18e-05	0.00144	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.16e-05	0.00143	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.16e-05	0.00143	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	3.14e-05	0.00143	CbGpPWpGaD
Flunitrazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	3.14e-05	0.00143	CbGpPWpGaD
Flunitrazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	3.1e-05	0.00141	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	3.06e-05	0.00139	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—EP300—uterine cancer	3.04e-05	0.00138	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	3.02e-05	0.00137	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—STAR—uterine cancer	2.99e-05	0.00136	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—AKR1B1—uterine cancer	2.99e-05	0.00136	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.96e-05	0.00134	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.92e-05	0.00133	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—POLD1—uterine cancer	2.89e-05	0.00131	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.88e-05	0.00131	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.88e-05	0.00131	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	2.88e-05	0.00131	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—RRM2—uterine cancer	2.83e-05	0.00129	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	2.82e-05	0.00128	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	2.78e-05	0.00126	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.76e-05	0.00125	CbGpPWpGaD
Flunitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2.75e-05	0.00125	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—DCN—uterine cancer	2.75e-05	0.00125	CbGpPWpGaD
Flunitrazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2.7e-05	0.00123	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—AKR1C1—uterine cancer	2.7e-05	0.00123	CbGpPWpGaD
Flunitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2.66e-05	0.00121	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.6e-05	0.00118	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CYP11A1—uterine cancer	2.59e-05	0.00118	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—NDUFB11—uterine cancer	2.57e-05	0.00117	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—SRD5A2—uterine cancer	2.57e-05	0.00117	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—NDUFB11—uterine cancer	2.52e-05	0.00115	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—SRD5A2—uterine cancer	2.52e-05	0.00115	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.46e-05	0.00112	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.46e-05	0.00112	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—AKR1C3—uterine cancer	2.45e-05	0.00111	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—RRM2—uterine cancer	2.41e-05	0.00109	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—HRAS—uterine cancer	2.36e-05	0.00107	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—POLD1—uterine cancer	2.35e-05	0.00107	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—DCN—uterine cancer	2.34e-05	0.00106	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—HRAS—uterine cancer	2.33e-05	0.00106	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.32e-05	0.00105	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—AKR1B1—uterine cancer	2.31e-05	0.00105	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—STAR—uterine cancer	2.31e-05	0.00105	CbGpPWpGaD
Flunitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2.27e-05	0.00103	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.21e-05	0.001	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CYP11A1—uterine cancer	2.2e-05	0.001	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—AKR1C1—uterine cancer	2.2e-05	0.000998	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.18e-05	0.000989	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.15e-05	0.000975	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.11e-05	0.00096	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—AKR1C3—uterine cancer	2.08e-05	0.000945	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—HRAS—uterine cancer	2.07e-05	0.000941	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—HRAS—uterine cancer	2.03e-05	0.000924	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—HRAS—uterine cancer	2e-05	0.000908	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—RRM2—uterine cancer	1.96e-05	0.000889	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—NDUFB11—uterine cancer	1.95e-05	0.000884	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—SRD5A2—uterine cancer	1.95e-05	0.000884	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—STK11—uterine cancer	1.91e-05	0.000866	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CYP19A1—uterine cancer	1.91e-05	0.000866	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—DCN—uterine cancer	1.9e-05	0.000863	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.89e-05	0.000858	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—STAR—uterine cancer	1.86e-05	0.000846	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—AKR1B1—uterine cancer	1.86e-05	0.000846	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—AKR1B1—uterine cancer	1.82e-05	0.000828	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—STAR—uterine cancer	1.82e-05	0.000828	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—POLD1—uterine cancer	1.81e-05	0.000822	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—HRAS—uterine cancer	1.81e-05	0.000821	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.81e-05	0.000821	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CYP11A1—uterine cancer	1.79e-05	0.000813	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—HRAS—uterine cancer	1.79e-05	0.000811	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.78e-05	0.000811	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.77e-05	0.000806	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.77e-05	0.000806	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.72e-05	0.000783	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—HRAS—uterine cancer	1.7e-05	0.000774	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—AKR1C1—uterine cancer	1.69e-05	0.000769	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—AKR1C3—uterine cancer	1.69e-05	0.000768	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.63e-05	0.000739	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—STK11—uterine cancer	1.62e-05	0.000736	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CYP19A1—uterine cancer	1.62e-05	0.000736	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—HRAS—uterine cancer	1.59e-05	0.000721	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—HRAS—uterine cancer	1.56e-05	0.000708	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—HRAS—uterine cancer	1.53e-05	0.000696	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.52e-05	0.000689	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.52e-05	0.000689	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—RRM2—uterine cancer	1.51e-05	0.000686	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.47e-05	0.000669	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—DCN—uterine cancer	1.47e-05	0.000666	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—POLD1—uterine cancer	1.46e-05	0.000664	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—MTHFR—uterine cancer	1.43e-05	0.000651	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—POLD1—uterine cancer	1.43e-05	0.00065	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.41e-05	0.000639	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—STAR—uterine cancer	1.41e-05	0.000639	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.39e-05	0.000632	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.39e-05	0.000632	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYP11A1—uterine cancer	1.38e-05	0.000627	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—AKR1C1—uterine cancer	1.37e-05	0.000621	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—AKR1C1—uterine cancer	1.34e-05	0.000608	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CYP19A1—uterine cancer	1.32e-05	0.000598	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—STK11—uterine cancer	1.32e-05	0.000598	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—HRAS—uterine cancer	1.31e-05	0.000593	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—AKR1C3—uterine cancer	1.3e-05	0.000592	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.28e-05	0.000583	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—STAR—uterine cancer	1.28e-05	0.000583	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.27e-05	0.000576	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—MTHFR—uterine cancer	1.22e-05	0.000553	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—RRM2—uterine cancer	1.22e-05	0.000553	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—RRM2—uterine cancer	1.19e-05	0.000542	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—DCN—uterine cancer	1.18e-05	0.000537	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.17e-05	0.000531	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.17e-05	0.000531	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—DCN—uterine cancer	1.16e-05	0.000526	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.11e-05	0.000506	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—POLD1—uterine cancer	1.1e-05	0.000501	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.1e-05	0.000498	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—STAR—uterine cancer	1.1e-05	0.000498	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.09e-05	0.000496	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.08e-05	0.000492	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—AKR1C3—uterine cancer	1.05e-05	0.000478	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.03e-05	0.000469	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.03e-05	0.000468	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—STK11—uterine cancer	1.02e-05	0.000461	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYP19A1—uterine cancer	1.02e-05	0.000461	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—POLD1—uterine cancer	1.01e-05	0.000457	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—MTHFR—uterine cancer	9.9e-06	0.00045	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—AKR1C1—uterine cancer	9.41e-06	0.000428	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—RRM2—uterine cancer	9.2e-06	0.000418	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—DCN—uterine cancer	8.93e-06	0.000406	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—POLD1—uterine cancer	8.6e-06	0.000391	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—STAR—uterine cancer	8.46e-06	0.000384	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—AKR1B1—uterine cancer	8.46e-06	0.000384	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP11A1—uterine cancer	8.42e-06	0.000382	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—RRM2—uterine cancer	8.39e-06	0.000381	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—STK11—uterine cancer	8.19e-06	0.000372	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP19A1—uterine cancer	8.19e-06	0.000372	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—DCN—uterine cancer	8.14e-06	0.00037	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—AKR1C1—uterine cancer	8.04e-06	0.000365	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—STK11—uterine cancer	8.03e-06	0.000365	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYP19A1—uterine cancer	8.03e-06	0.000365	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PTEN—uterine cancer	7.97e-06	0.000362	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—AKR1C3—uterine cancer	7.95e-06	0.000361	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP11A1—uterine cancer	7.67e-06	0.000349	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—MTHFR—uterine cancer	7.63e-06	0.000347	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—EP300—uterine cancer	7.6e-06	0.000345	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—AKR1C3—uterine cancer	7.25e-06	0.000329	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—RRM2—uterine cancer	7.17e-06	0.000326	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—DCN—uterine cancer	6.96e-06	0.000316	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PTEN—uterine cancer	6.78e-06	0.000308	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—POLD1—uterine cancer	6.64e-06	0.000302	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP11A1—uterine cancer	6.56e-06	0.000298	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—EP300—uterine cancer	6.46e-06	0.000294	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—AKR1C1—uterine cancer	6.21e-06	0.000282	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—AKR1C3—uterine cancer	6.19e-06	0.000281	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—STK11—uterine cancer	6.19e-06	0.000281	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP19A1—uterine cancer	6.19e-06	0.000281	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—MTHFR—uterine cancer	6.16e-06	0.00028	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—MTHFR—uterine cancer	6.03e-06	0.000274	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.81e-06	0.000264	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—STK11—uterine cancer	5.65e-06	0.000256	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP19A1—uterine cancer	5.65e-06	0.000256	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PIK3CA—uterine cancer	5.62e-06	0.000255	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.54e-06	0.000252	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—RRM2—uterine cancer	5.53e-06	0.000251	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTEN—uterine cancer	5.51e-06	0.00025	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—DCN—uterine cancer	5.37e-06	0.000244	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.3e-06	0.000241	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—EP300—uterine cancer	5.25e-06	0.000239	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP11A1—uterine cancer	5.06e-06	0.00023	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.05e-06	0.00023	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—STK11—uterine cancer	4.82e-06	0.000219	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP19A1—uterine cancer	4.82e-06	0.000219	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PIK3CA—uterine cancer	4.78e-06	0.000217	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.78e-06	0.000217	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—MTHFR—uterine cancer	4.65e-06	0.000211	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—AKT1—uterine cancer	4.59e-06	0.000209	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.53e-06	0.000206	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.32e-06	0.000196	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTEN—uterine cancer	4.25e-06	0.000193	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—MTHFR—uterine cancer	4.24e-06	0.000193	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.1e-06	0.000186	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—EP300—uterine cancer	4.05e-06	0.000184	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—AKT1—uterine cancer	3.91e-06	0.000177	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CA—uterine cancer	3.89e-06	0.000176	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.74e-06	0.00017	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—STK11—uterine cancer	3.72e-06	0.000169	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.72e-06	0.000169	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—MTHFR—uterine cancer	3.63e-06	0.000165	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTEN—uterine cancer	3.43e-06	0.000156	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTEN—uterine cancer	3.35e-06	0.000152	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—EP300—uterine cancer	3.27e-06	0.000148	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—EP300—uterine cancer	3.2e-06	0.000145	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.19e-06	0.000145	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—AKT1—uterine cancer	3.17e-06	0.000144	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CA—uterine cancer	2.99e-06	0.000136	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—MTHFR—uterine cancer	2.8e-06	0.000127	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTEN—uterine cancer	2.59e-06	0.000118	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—EP300—uterine cancer	2.47e-06	0.000112	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—AKT1—uterine cancer	2.45e-06	0.000111	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CA—uterine cancer	2.42e-06	0.00011	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CA—uterine cancer	2.37e-06	0.000108	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTEN—uterine cancer	2.36e-06	0.000107	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—EP300—uterine cancer	2.25e-06	0.000102	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTEN—uterine cancer	2.02e-06	9.16e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—AKT1—uterine cancer	1.97e-06	8.97e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—AKT1—uterine cancer	1.93e-06	8.78e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—EP300—uterine cancer	1.92e-06	8.74e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.83e-06	8.3e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.66e-06	7.56e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTEN—uterine cancer	1.56e-06	7.07e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—AKT1—uterine cancer	1.49e-06	6.78e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—EP300—uterine cancer	1.48e-06	6.74e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.42e-06	6.46e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—AKT1—uterine cancer	1.36e-06	6.18e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—AKT1—uterine cancer	1.16e-06	5.28e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.1e-06	4.99e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—AKT1—uterine cancer	8.97e-07	4.08e-05	CbGpPWpGaD
